Caspase inhibition in liver transplantation: From basic research to clinical studies

HPB

Volumn 12, Issue 1, 2010, Pages 1-3

  Cursio, Raffaele ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [(2 TERT BUTYLPHENYLAMINOOXALYL)AMINO]PROPIONYLAMINO] 4 OXO 5 (2,3,5,6 TETRAFLUOROPHENOXY)PENTANOIC ACID; CASPASE; CASPASE 10; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CHEMOKINE; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BODY TEMPERATURE; CELL DEATH; CELL SURVIVAL; CLINICAL TRIAL; CRYOPRESERVATION; DRUG HALF LIFE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT PRESERVATION; HUMAN; IMMUNE RESPONSE; LIVER CELL; LIVER GRAFT; LIVER ISCHEMIA; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW;

EID: 75449087649     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2009.00123.x     Document Type: Article

References (18)

1. Farmer DG, Amersi F, Kupiec-Weglinski JW. (2000) Current status of ischemia and reperfusion injury in the liver. Transpl Rev 14:106-126.
2. Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimaki K. (1992) Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16:454-561.
3. Silva AM, Mirza DF, Murphy N, Richards DA, Reynolds GM, Wigmore SJ et al. (2008) Intrahepatic complement activation, sinusoidal endothelial injury, and lactic acidosis are associated with initial poor function of the liver after transplantation. Transplantation 85:718-725.
4. Selzner N, Rudiger H, Graf R, Clavien PA. (2003) Protective strategies against ischemic injury of the liver. Gastroenterology 125:917-936.
5. Malhi H, Gores JG, Lemasters JJ. (2006) Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43:S31-S44.
6. Thornberry NA, Lazebnik Y. (1998) Caspases: enemies within. Science 281:1312-1316.
7. Defamie V, Cursio R, Lebrigand K, Moreilhon C, Saint-Paul M-C, Laurens M et al. (2008) Gene expression profiling of human liver transplants identifies an early transcriptional signature associated with initial poor graft function. Am J Transpl 8:1221-1236.
8. Cursio R, Colosetti P, Auberger P, Gugenheim J. (2008) Liver apoptosis following normothermic ischemia-reperfusion: in vivo evaluation of caspase activity by FLIVO assay in rats. Transpl Proc 40:2038-2041.
9. Cursio R, Gugenheim J, Ricci JE, Crenesse D, Rostagno P, Maulon L et al. (1999) A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J 13: 253-261.
10. Natori S, Higuchi H, Contreras P, Gores GJ. (2003) The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl 9: 278-284.
11. Hoglen NC, Anselmo DM, Katori M, Kaldas M, Shen X-D, Valentino KL et al. (2007) A caspase inhibitor, IDN-6556, ameliorates early hepatic injury in an ex vivo model of warm and cold ischemia. Liver Transpl 13:361-366.
12. Martinet W, Schrjvers DM, Herman AG, De Meyer GRY. (2006) Z-VADfmk-induced non-apoptotic cell death of macrophages. Autophagy 2:312-314.
13. Galluzzi L, Kroemer G. (2008) Necroptosis: a specialized pathway of programmed necrosis. Cell 135:1161-1163.
14. Vandenabeele P, Vanden Berghe T, Festjens N. (2006) Caspase inhibitors promote alternative cell death pathways. Sci STKE 358:pe44.
15. Nicholson DW. (2000) From bench to clinic with apoptosis-based therapeutic agents. Nature 407:810-816.
16. Valentino KL, Gutierrez M, Sanchez R, Winship MJ, Shapiro DA. (2003) First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes. Int J Clin Pharmacol Ther 41:441-449.
17. Pockros PJ, Schiff ER. Schiffman ML, McHutchison JG, Gish RG, Afdhal NH et al. (2007) Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. Hepatology 46:324-329.
18. Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M-R et al. (2007) Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transpl 7:218-225.